Barry D. Quart, President and CEO at Ardea Biosciences, Inc./DE (RDEA), sold 30,500 shares at $14.48 ($362K) on 2009-12-09, disclosed to the SEC on 2009-12-11.
Scheduled sale ($362k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.48 | 25,000 | $362K | 100.0% |
| 2 | $0.00 | 5,500 | $0 | 0.0% |
| Total | $11.87 avg | 30,500 | $362K | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |